| scholarly article | Q13442814 |
| P50 | author | Hiroyasu Nakano | Q55277402 |
| Norihiro Harada | Q73561892 | ||
| P2093 | author name string | Hideo Yagita | |
| Ko Okumura | |||
| Yoshinosuke Fukuchi | |||
| Masafumi Nakayama | |||
| P2860 | cites work | A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis | Q24291951 |
| Identification of a ligand for the death-domain-containing receptor Apo3 | Q24310256 | ||
| The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas | Q24681487 | ||
| Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies | Q24803611 | ||
| Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3) | Q28138623 | ||
| TWEAK induces angiogenesis and proliferation of endothelial cells | Q28139175 | ||
| Multiple pathways of TWEAK-induced cell death | Q28214614 | ||
| TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis | Q28257134 | ||
| CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase | Q28270530 | ||
| Apoptosis by death factor | Q28304002 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
| The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B | Q29618194 | ||
| The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems | Q33876783 | ||
| Signaling by the TNF receptor superfamily and T cell homeostasis | Q34078765 | ||
| Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity | Q36369095 | ||
| Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers | Q38299782 | ||
| TWEAK can induce cell death via endogenous TNF and TNF receptor 1. | Q38323407 | ||
| Current and future clinical applications of interferon-gamma in host antimicrobial defense | Q40924880 | ||
| Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment | Q41036449 | ||
| Cytokine regulation of endothelial cell function: from molecular level to the bedside | Q41472342 | ||
| Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis | Q41603425 | ||
| A simple, non-chromatographic purification procedure for monoclonal antibodies. Isolation of monoclonal antibodies against cytochrome P450 isozymes | Q69062667 | ||
| Conserved Glu318 at the cytochrome P450 1A2 distal site is crucial in the nitric oxide complex stability | Q71058638 | ||
| TWEAK stimulation of astrocytes and the proinflammatory consequences | Q74280324 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| endothelium | Q111140 | ||
| P304 | page(s) | 488-493 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells | |
| P478 | volume | 299 |
| Q38123074 | A further TWEAK to multiple sclerosis pathophysiology |
| Q35083662 | A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia |
| Q36690605 | Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL |
| Q39704685 | Antiangiogenic activity of ursolic acid. |
| Q30724766 | BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis |
| Q35954775 | Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD. |
| Q28592715 | Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies |
| Q26995211 | Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage |
| Q42776466 | Connective Tissue Growth Factor Promotes Efficient Generation of Human Induced Pluripotent Stem Cell-Derived Choroidal Endothelium |
| Q27678102 | Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding |
| Q85167906 | Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury |
| Q36546646 | Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb. |
| Q28211919 | Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth |
| Q37071856 | Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis. |
| Q37724036 | Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice |
| Q40555106 | Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation |
| Q39778302 | Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells |
| Q54571749 | Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. |
| Q34291063 | Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression |
| Q53540861 | Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis. |
| Q38021183 | Role of TWEAK in lupus nephritis: a bench-to-bedside review |
| Q38317752 | Role of strain differences on host resistance and the transcriptional response of macrophages to infection with Yersinia enterocolitica. |
| Q44740069 | Serum TNF-related and weak inducer of apoptosis levels in septic shock patients |
| Q37415728 | Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease |
| Q46354917 | Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function |
| Q34993747 | Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis |
| Q39406226 | TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation |
| Q28749137 | TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21 |
| Q37697186 | TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion |
| Q34206359 | TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus |
| Q35092962 | TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. |
| Q37295055 | TWEAK and Fn14 in the Neurovascular Unit |
| Q37722596 | TWEAK as a target for therapy in systemic lupus erythematosus. |
| Q24553352 | TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules |
| Q41870284 | TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice |
| Q38885125 | TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells. |
| Q31148506 | TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. |
| Q33860715 | TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis. |
| Q40641517 | TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor |
| Q27318227 | TWEAK promotes peritoneal inflammation |
| Q57245504 | TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells |
| Q42361200 | TWEAK/Fn14 Activation Participates in Skin Inflammation |
| Q37494039 | TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases. |
| Q53382894 | TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation. |
| Q35605699 | TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells |
| Q38668064 | TWEAK/Fn14 signaling in tumors |
| Q38177788 | TWEAK: A New Player in Obesity and Diabetes. |
| Q38991116 | Targeting STOX1 in the therapy of preeclampsia |
| Q94418605 | The Evaluation of Serum Tumor Necrosis Factor-Like Weak Inducer of Apoptosis, Interleukin-6, Fetuin-A, Homeostatic Model Assessment-Insulin Resistance, and Insulin Levels in Rheumatoid Arthritis Patients in Clinical Remission |
| Q40677513 | The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation |
| Q37135363 | The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting |
| Q36666882 | The cytokine TWEAK modulates renal tubulointerstitial inflammation |
| Q35850469 | The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system |
| Q34171150 | The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain |
| Q38638020 | The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors |
| Q35450066 | The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy. |
| Q28299334 | The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression |
| Q36230448 | Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer |
| Q89696547 | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges |
| Q63988279 | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration |
| Q34348370 | Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death |
| Q37980604 | Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis |
| Q42250250 | Tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 are expressed in urticarial vasculitis |
| Q48708341 | Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. |
| Q35026182 | Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice. |
| Q53489723 | Tumor necrosis factor-like weak inducer of apoptosis regulates the phenotype and cytotoxic activity of goat uterine natural killer cells. |
| Q39506124 | Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura |
| Q40453290 | Tweak induces mammary epithelial branching morphogenesis. |
| Q35893298 | Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia |
| Q50988060 | Tweak up-regulates endothelin-1 system in mouse and human endothelial cells. |
| Q37453911 | Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. |
Search more.